{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:59:18Z","timestamp":1791845958489,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T00:00:00Z","timestamp":1644710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ymeth.2022.02.004","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T11:11:15Z","timestamp":1644664275000},"page":"498-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations"],"prefix":"10.1016","volume":"203","author":[{"given":"Michal","family":"Lazniewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doni","family":"Dermawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syahrul","family":"Hidayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muchtaridi","family":"Muchtaridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne K.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Plewczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymeth.2022.02.004_b0005","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1038\/s41467-021-22785-x","article-title":"The architecture of the SARS-CoV-2 RNA genome inside virion","volume":"12","author":"Cao","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ymeth.2022.02.004_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/01.PDR.0000129184.87042.FC","article-title":"SARS: the first pandemic of the 21st century","volume":"56","author":"Cherry","year":"2004","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.ymeth.2022.02.004_b0015","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01062-13","article-title":"Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus","volume":"5","author":"Cotten","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.ymeth.2022.02.004_b0020","first-page":"428","article-title":"Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae)","author":"Liu","year":"2020","journal-title":"Encycloped. Virol."},{"issue":"1","key":"10.1016\/j.ymeth.2022.02.004_b0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12014-021-09325-x","article-title":"Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants","volume":"18","author":"Rais","year":"2021","journal-title":"Clin. Proteomics"},{"issue":"7807","key":"10.1016\/j.ymeth.2022.02.004_b0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ymeth.2022.02.004_b0035","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ymeth.2022.02.004_b0040","article-title":"Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2","volume":"7","author":"Salamanna","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"issue":"36","key":"10.1016\/j.ymeth.2022.02.004_b0045","doi-asserted-by":"crossref","first-page":"22311","DOI":"10.1073\/pnas.2010146117","article-title":"Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates","volume":"117","author":"Damas","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1963","key":"10.1016\/j.ymeth.2022.02.004_b0050","first-page":"20211651","article-title":"Predicting the zoonotic capacity of mammals to transmit SARS-CoV-2","volume":"288","author":"Fischhoff","year":"2021","journal-title":"Proc. Biol. Sci."},{"issue":"6","key":"10.1016\/j.ymeth.2022.02.004_b0055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41422-021-00490-0","article-title":"Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2","volume":"31","author":"Yan","year":"2021","journal-title":"Cell Res."},{"issue":"7837","key":"10.1016\/j.ymeth.2022.02.004_b0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41586-020-2772-0","article-title":"Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion","volume":"588","author":"Benton","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ymeth.2022.02.004_b0065","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","article-title":"Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics","volume":"20","author":"Petersen","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.ymeth.2022.02.004_b0070","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.02062-10","article-title":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry","volume":"85","author":"Shulla","year":"2011","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.ymeth.2022.02.004_b0075","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.ajpath.2021.04.010","article-title":"ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients","volume":"191","author":"Ramos","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.ymeth.2022.02.004_b0080","doi-asserted-by":"crossref","first-page":"19522","DOI":"10.1038\/s41598-020-76488-2","article-title":"SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells","volume":"10","author":"Sidarta-Oliveira","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ymeth.2022.02.004_b0085","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/01.HYP.0000188905.20884.63","article-title":"Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors","volume":"46","author":"Chen","year":"2005","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ymeth.2022.02.004_b0090","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ymeth.2022.02.004_b0095","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59177","article-title":"A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm","volume":"9","author":"Garvin","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ymeth.2022.02.004_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.625732","article-title":"Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1\u20137) Is Modulated in COVID-19 Patients","volume":"12","author":"Osman","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ymeth.2022.02.004_b0105","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veab064","article-title":"Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool","volume":"7","author":"O\u2019Toole","year":"2021","journal-title":"Virus Evol."},{"key":"10.1016\/j.ymeth.2022.02.004_b0110","unstructured":"S.A. Kemp, D.A. Collier, R.P. Datir, I. Ferreira, S. Gayed, A. Jahun, M. Hosmillo, C. Rees-Spear, P. Mlcochova, I.U. Lumb, D.J. Roberts, A. Chandra, N. Temperton, C.-N.B.C.-. Collaboration, C.-G.U. Consortium, K. Sharrocks, E. Blane, Y. Modis, K.E. Leigh, J.A.G. Briggs, M.J. van Gils, K.G.C. Smith, J.R. Bradley, C. Smith, R. Doffinger, L. Ceron-Gutierrez, G. Barcenas-Morales, D.D. Pollock, R.A. Goldstein, A. Smielewska, J.P. Skittrall, T. Gouliouris, I.G. Goodfellow, E. Gkrania-Klotsas, C.J.R. Illingworth, L.E. McCoy, R.K. Gupta, SARS-CoV-2 evolution during treatment of chronic infection, Nature 592(7853) (2021) 277-282."},{"key":"10.1016\/j.ymeth.2022.02.004_b0115","series-title":"Assessment of the further emergence and potential impact of the SARS-CoV-2 Omicron variant of concern in the context of ongoing transmission of the Delta variant of concern in the EU\/EEA, 18th update - 15 December 2021","author":"European Centre for Disease Prevention and Control","year":"2021"},{"key":"10.1016\/j.ymeth.2022.02.004_b0120","doi-asserted-by":"crossref","unstructured":"T. Harder, W. Kulper-Schiek, S. Reda, M. Treskova-Schwarzbach, J. Koch, S. Vygen-Bonnet, O. Wichmann, Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021, Euro Surveill 26(41) (2021).","DOI":"10.2807\/1560-7917.ES.2021.26.41.2100920"},{"issue":"2","key":"10.1016\/j.ymeth.2022.02.004_b0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1473-3099(21)00648-4","article-title":"Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study","volume":"22","author":"Singanayagam","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"30","key":"10.1016\/j.ymeth.2022.02.004_b0130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024302118","article-title":"Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay","volume":"118","author":"Jang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.ymeth.2022.02.004_b0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/14787210.4.2.291","article-title":"Potential antivirals and antiviral strategies against SARS coronavirus infections","volume":"4","author":"De Clercq","year":"2006","journal-title":"Expert. Rev. Anti Infect. Ther."},{"issue":"1","key":"10.1016\/j.ymeth.2022.02.004_b0140","doi-asserted-by":"crossref","first-page":"21872","DOI":"10.1038\/s41598-021-01410-3","article-title":"Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis","volume":"11","author":"MotieGhader","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymeth.2022.02.004_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.636989","article-title":"Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease","volume":"12","author":"Pinzi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymeth.2022.02.004_b0150","article-title":"Drug Repurposing to Identify Therapeutics Against COVID 19 with SARS-Cov-2 Spike Glycoprotein and Main Protease as Targets: An in Silico Study","author":"Arun","year":"2020","journal-title":"ChemRxiv"},{"issue":"8","key":"10.1016\/j.ymeth.2022.02.004_b0155","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1021\/acs.jcim.1c00384","article-title":"Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns","volume":"61","author":"Mslati","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"10.1016\/j.ymeth.2022.02.004_b0160","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12498","article-title":"Current treatment strategies for COVID19 (Review)","volume":"24","author":"Han","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.ymeth.2022.02.004_b0165","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/17425255.2019.1685495","article-title":"Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV","volume":"15","author":"Cattaneo","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"11","key":"10.1016\/j.ymeth.2022.02.004_b0170","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15\u2013Ligand Discovery for Everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"5","key":"10.1016\/j.ymeth.2022.02.004_b0175","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"18","key":"10.1016\/j.ymeth.2022.02.004_b0180","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1016\/j.bmcl.2006.06.076","article-title":"Replacing the cyclohexene-linker of FR181157 leading to novel IP receptor agonists: orally active prostacyclin mimetics. Part 6","volume":"16","author":"Tanaka","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"16","key":"10.1016\/j.ymeth.2022.02.004_b0185","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"67","key":"10.1016\/j.ymeth.2022.02.004_b0190","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.21105\/joss.03773","article-title":"Nextclade: clade assignment, mutation calling and quality control for viral genomes","volume":"6","author":"Aksamentov","year":"2021","journal-title":"J. Open Sour. Softw."},{"issue":"1","key":"10.1016\/j.ymeth.2022.02.004_b0195","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ymeth.2022.02.004_b0200","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol. Biol. Evol."},{"issue":"3","key":"10.1016\/j.ymeth.2022.02.004_b0205","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ymeth.2022.02.004_b0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: More and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"issue":"2","key":"10.1016\/j.ymeth.2022.02.004_b0215","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1021\/acs.jctc.0c01006","article-title":"Accelerating AutoDock4 with GPUs and Gradient-Based Local Search","volume":"17","author":"Santos-Martins","year":"2021","journal-title":"J. Chem. Theory Comput."},{"issue":"W1","key":"10.1016\/j.ymeth.2022.02.004_b0220","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.ymeth.2022.02.004_b0225","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","article-title":"Gromacs 4.5: a high-throughput and highly parallel open source molecular simulation toolkit","volume":"29","author":"Pronk","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymeth.2022.02.004_b0230","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1756-0500-5-367","article-title":"ACPYPE - AnteChamber PYthon Parser interfacE","volume":"5","author":"Sousa da Silva","year":"2012","journal-title":"BMC Res Notes"},{"issue":"16","key":"10.1016\/j.ymeth.2022.02.004_b0235","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"7","key":"10.1016\/j.ymeth.2022.02.004_b0240","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"Open Source Drug Discovery, A. Lynn, g_mmpbsa\u2013a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ymeth.2022.02.004_b0245","doi-asserted-by":"crossref","unstructured":"Y. Liu, J. Liu, K.S. Plante, J.A. Plante, X. Xie, X. Zhang, Z. Ku, Z. An, D. Scharton, C. Schindewolf, V.D. Menachery, P.Y. Shi, S.C. Weaver, The N501Y spike substitution enhances SARS-CoV-2 transmission, bioRxiv (2021).","DOI":"10.1101\/2021.03.08.434499"},{"issue":"4","key":"10.1016\/j.ymeth.2022.02.004_b0250","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jcc.21643","article-title":"Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database","volume":"32","author":"Plewczynski","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ymeth.2022.02.004_b0255","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-021-02177-3","article-title":"Remember Beta? New data reveal variant's deadly powers","author":"Callaway","year":"2021","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ymeth.2022.02.004_b0260","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1021\/jm050085k","article-title":"Discovery of diphenyloxazole and Ndelta-Z-ornithine derivatives as highly potent and selective human prostaglandin EP(4) receptor antagonists","volume":"48","author":"Hattori","year":"2005","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ymeth.2022.02.004_b0265","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0968-0896(98)00133-3","article-title":"Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series","volume":"6","author":"Mary","year":"1998","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.ymeth.2022.02.004_b0270","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/1062936X.2021.1993995","article-title":"Discovery of Zafirlukast as a novel SARS-CoV-2 helicase inhibitor using in silico modelling and a FRET-based assay","volume":"32","author":"Mehyar","year":"2021","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.ymeth.2022.02.004_b0275","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.csbj.2020.12.028","article-title":"Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2","volume":"19","author":"Kumar","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ymeth.2022.02.004_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108412","article-title":"Levocetirizine and montelukast in the COVID-19 treatment paradigm","volume":"103","author":"May","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymeth.2022.02.004_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.132041","article-title":"Ligand-based quantitative structural assessments of SARS-CoV-2 3CL(pro) inhibitors: An analysis in light of structure-based multi-molecular modeling evidences","volume":"1251","author":"Adhikari","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ymeth.2022.02.004_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131920","article-title":"Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors","volume":"1250","author":"Uddin","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ymeth.2022.02.004_b0295","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.678701","article-title":"Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental Pipeline","volume":"8","author":"Lau","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.ymeth.2022.02.004_b0300","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021579118","article-title":"Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection","volume":"118","author":"Jan","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymeth.2022.02.004_b0305","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1073\/pnas.181342398","article-title":"Electrostatics of nanosystems: application to microtubules and the ribosome","volume":"98","author":"Baker","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202322000329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202322000329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:50:03Z","timestamp":1760925003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202322000329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":61,"alternative-id":["S1046202322000329"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2022.02.004","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2022.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}